Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_assertion type Assertion NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_head.
- NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_assertion description "[Point mutations in KRAS, BRAF, and PIK3CA and ERBB2 amplification were determined in primary tumors from 63 patients with locally advanced rectal cancer scheduled for radical treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_provenance.
- NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_assertion evidence source_evidence_literature NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_provenance.
- NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_assertion SIO_000772 23226389 NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_provenance.
- NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_assertion wasDerivedFrom befree-2016 NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_provenance.
- NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_assertion wasGeneratedBy ECO_0000203 NP1034875.RAefcdnFBYIN-c7pH1MMlp7GqjrxzlT-YBnM0PBfubK2Q130_provenance.